Expression of Apoptosis-Related Proteins and Structural Features of Cell Death in Explanted Aortocoronary Saphenous Vein Bypass Grafts

Abstract

This study aimed to investigate the features of cell death occurring in aortocoronary saphenous vein bypass grafts. Human aortocoronary saphenous vein bypass grafts with angiographic luminal stenosis of >75% were explanted from 14 patients at redo coronary artery bypass grafting. Proteins associated with apoptotic pathways were identified immunohistochemically using antibodies to Bcl-2, Fas, BAX, p53 and CPP32. Cells undergoing DNA fragmentation were identified by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). DNA synthesis was investigated using the antibody to proliferating cell nuclear antigen (PCNA). Ultrastructural features of cell death were examined by electron microscopy. Anti-apoptotic (Bcl-2) and pro-apoptotic (Bax, p53, CPP32 and Fas) proteins were expressed throughout the graft wall, but marked differences in the characteristics of cell death were noted between atherosclerotic and non-atherosclerotic areas of the intima. In atherosclerotic areas, pro-apoptotic proteins were widely expressed, but ultrastructural analysis failed to identify cells showing typical features of apoptosis. In these areas, necrotic cells were frequently observed, with negative correlation of Bcl-2 expression with TUNEL. Pro-apoptotic proteins showed no correlation with TUNEL. In contrast, in non-atherosclerotic areas of vein grafts, the expression of both anti-apoptotic (Bcl-2) and pro-apoptotic proteins (p53. Bax and CPP32) correlated with TUNEL. In atherosclerotic areas, non-atherosclerotic intimal areas, and in the underlying media, the numbers of TUNEL+ cells correlated with PCNA positivity. Ultrastructurally, apoptotic bodies and features of necrosis were observed in non-atherosclerotic areas of grafts. The present observations indicate that in atherosclerotic areas, cell death occurs mainly by necrosis, while in non-atherosclerotic areas, cell death occurs by both necrosis and apoptosis. An imbalance between DNA fragmentation and DNA synthesis may contribute to graft instability and failure.

Keywords

apoptosis atherosclerosis cell death coronary artery disease necrosis saphenous vein bypass grafts

References

Flemma

R. J.

Mullen

D. C.

Lepley

, Aortocoronary vein bypass grafting. In Vascular Grafts, eds Sawyer

P. N.

Kaplitt

M. J.

. Appleton Century Crofts, New York 1978.

Szilagyi

D. E.

, Atherogenesis in venous bypass grafts. In Vascular Grafts, eds Sawyer

P. N.

Kaplitt

M. J.

. Appleton Century Crofts, New York 1978.

Kirklin

J. K.

Barrat-Boyes

B. G.

, Ischaemic heart disease. In. Cardiac Surgery, Vol. 1 Churchill Livingston, Edinburgh. 1993.

Cambria

R. P.

Abbott

W. M.

, Translocated autogenous vein grafts. In., Vascular Surgery, Vol. 1 W. B. Saunders Company, Sydney 1989.

Nielsen

T. G.

Laursen

Gronholdt

M. L.

, Histopathological features of in situ vein bypass stenoses. European Journal of Vascular and Endovascular Surgery, 1997, 14 492–498.

Motwani

J. G.

Topol

E. J.

, Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation, 1998, 97 916–931.

Meyer

Baumgardt

Lofeler

, Apoptosis in combined liver/small bowel transplantation. Transplantation Proceedings, 1998, 30, 2588.

Schierle

G. S.

Hansson

Leist

, Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nature Medicine, 1999, 5 97–100.

Cagiannos

Zhong

Zang

, Effect of major histocompatibility complex expression on murine intestinal graft survival. Transplantation, 1998, 66 1369–1374.

10.

Hayakawa

Sato

Aoyagi

, Apoptosis in acute cellular rejection in murine renal allotransplantation. Transplantation Proceedings, 1998, 30 2944–2946.

11.

Hayashi

Martinez

O. M.

Krams

S. M.

, Characterization of allograft rejection in an experimental model of small intestinal transplantation. Journal of Gastrointestinal Surgery, 1998, 2 325–332.

12.

Kageyama

X. K.

Suzuki

, Apoptosis is involved in acute cardiac allograft rejection in rats. Annals of Thoracic Surgery, 1998, 65 1604–1609.

13.

Kirsch

G. M.

Kearsey

Butr

, Medial smooth muscle cell loss in arterial allografts occurs by cytolytic cell induced apoptosis. European Journal of Cardiothoracic Surgery, 1998, 14 89–96.

14.

Krams

S. M.

Martinez

O. M.

, Apoptosis as a mechanism of tissue injury in liver allograft rejection. Seminars in Liver Disease, 1998, 18 153–167.

15.

Boonman

Isacson

, Apoptosis in neuronal development and transplantation: role of caspases and trophic factors. Experimental Neurology, 1999, 156 1–15.

16.

Vriens

P. W.

Blankenberg

F. G.

Stoot

J. H.

, The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. Journal of Thoracic and Cardiovascular Surgery, 1998, 116 844–853.

17.

Fandrich

Dresske

Lin

, Allopeptide-mediated expression of endothelial Fas-ligand (CD95L) in long-term tolerized heterotopic rat heart grafts. Transplantation Proceedings, 1999, 31 1558–1559.

18.

Koglin

Granville

D. J.

Glysine-Jensen

, Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis. Circulation, 1999, 99 836–842.

19.

August

Schmid

K. W.

Dietl

K. H.

, Prognostic value of lymphocyte apoptosis in acute rejection of renal allografts. Transplantation, 1999, 67 581–585.

20.

Rabinovitch

Suarez-Pinzon

Trynadka

, Transfection of human pancreatic islets with an anti-apoptotic gene (Bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes, 1999, 48 1223–1229.

21.

Johnson

T. M.

Epstein

S. E.

Finkel

, Apoptosis in vascular disease: opportunities for genetic therapeutic intervention. Seminars in Interventional Cardiology, 1996, 1 195–202.

22.

Bennett

M. R.

, Apoptosis in vascular disease. Transplantation Immunology, 1997, 5 184–188.

23.

Maclouf

Folco

Patrono

, Eicosanoids and isoeicosanoids: constitutive, inducible and transcellular biosynthesis in vascular disease. Thrombosis and Haemostasis, 1998, 79 691–705.

24.

Murakami

Kawase

Kondo

, Cellular accumulation of extravasated serum protein and DNA fragmentation following vasogenic edema. Journal of Neurotrauma, 1998, 15 825–835.

25.

Pollman

M. J.

Hall

J. L.

Mann

M. J.

, Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nature Medicine, 1998, 4 222–227.

26.

Isner

J. M.

Kearney

Bortman

, Apoptosis in human atherosclerosis and restenosis. Circulation, 1995, 91 2703–2711.

27.

Crisby

Kallin

Thyberg

, Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis, 1997, 130 17–27.

28.

Lutgens

de Muinck

E. D.

Kitslaar

P. J.

, Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovascular Research, 1999, 41 473–479.

29.

Kearney

Pieczek

Haley

, Histopathology of instent restenosis in patients with peripheral artery disease. Circulation, 1997, 95 1998–2002.

30.

Kockx

M. M.

de Meyer

G. Y.

Bult

, Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis, 1996, 120 115–124.

31.

Harada

Chen

Ishibashi

, Apoptotic cell death in atherosclerotic plaques of hyperlipidemic knockout mice. Atherosclerosis, 1997, 135 235–239.

32.

Kockx

M. M.

de Meyer

G. R.

Buyssens

, Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circulation Research, 1998, 83 378–387.

33.

Lutgens

Daemen

Kockx

M. M.

, Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. Circulation, 1999, 99 276–283.

34.

Shindo

Ishibashi

Yokoyama

, Granulocytemacrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable rabbits. Circulation, 1999, 99 2150–2156.

35.

World Medical Association Inc World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovascular Research, 1997, 35 2–3.

36.

Cherian

S. M.

Bobryshev

Y. V.

Inder

S. J.

, Involvement of dendritic cells in long-term aortocoronary saphenous vein bypass graft failure. Cardiovascular Surgery, 1999, 7 508–518.

37.

Hsu

Raine

Fanger

, Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. Journal of Histochemistry and Cytochemistry, 1981, 29 577–580.

38.

Kressel

Groscurth

, Distinction of apoptotic and necrotic cell death by in situ labeling of fragmented DNA. Cell Tissue Research, 1994, 278 549–556.

39.

Gavrieli

Sherman

Ben-Sasson

S. A.

, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cell Biology, 1992, 119 493–501.

40.

Kimura

Sasano

Shimosegawa

, Ultrastructural and confocal laser scanning miroscopic examination of TUNEL-positive cells. Journal of Pathology, 1997, 181 235–242.

41.

Kockx

M. M.

, Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arteriosclerosis Thrombosis and Vascular Biology, 1998, 18 1519–1522.

42.

Kockx

M. M.

Herman

A. G.

, Apoptosis in atherogenesis: implications for plaque destabilization. European Heart Journal, 1998, 19 (Suppl G) G23–G28.

43.

Rekhter

M. D.

Gordon

, Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. American Journal of Pathology, 1995, 147 668–677.